NSE:JBCHEPHARM Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,102	1,151	882.15	769.34	565.44
Short-Term Investments	3,723	178.92	67.7	0.85	1.06
Trading Asset Securities	7,389	3,171	3,647	1,922	-
Cash & Short-Term Investments	12,213	4,501	4,596	2,692	566.5
Cash Growth	171.35%	-2.08%	70.74%	375.20%	-91.83%
Accounts Receivable	7,809	8,154	6,869	5,758	5,557
Other Receivables	373.34	95.76	160.06	275.92	411.27
Receivables	8,188	8,255	7,036	6,048	5,981
Inventory	6,834	5,290	5,025	4,305	4,100
Prepaid Expenses	174.61	190.14	163.23	167.05	120.4
Other Current Assets	1,684	991.77	1,713	2,069	1,764
Total Current Assets	29,094	19,227	18,533	15,280	12,532
Property, Plant & Equipment	6,728	6,566	6,349	5,764	5,668
Long-Term Investments	417.16	2,784	285.13	137.84	127.22
Goodwill	574.59	574.59	574.59	574.59	574.59
Other Intangible Assets	12,291	13,171	13,885	13,223	6,714
Long-Term Deferred Tax Assets	68.73	84.19	58.78	65.1	64.31
Other Long-Term Assets	511.23	326.35	250.14	486.97	386.74
Total Assets	49,686	42,738	39,941	35,539	26,074
Accounts Payable	3,910	4,107	3,563	2,386	2,245
Accrued Expenses	188.96	202.33	167.83	176.15	247.43
Short-Term Debt	-	138.04	153.43	280.18	263.15
Current Portion of Long-Term Debt	-	-	3,182	1,370	-
Current Portion of Leases	24.65	77.33	108.77	88.87	76.26
Current Income Taxes Payable	92.05	82.3	117.62	49.54	60.95
Current Unearned Revenue	4.5	10.84	12.19	11.83	17.06
Other Current Liabilities	1,692	1,705	1,378	1,181	927.51
Total Current Liabilities	5,912	6,323	8,682	5,544	3,837
Long-Term Debt	-	-	236.39	3,832	-
Long-Term Leases	11.25	63.53	96.38	153.21	206.18
Long-Term Unearned Revenue	35.82	19.01	16.99	24.93	31.66
Pension & Post-Retirement Benefits	3.9	3.39	0.62	6.01	5.12
Long-Term Deferred Tax Liabilities	1,842	1,773	1,492	1,028	475.59
Other Long-Term Liabilities	289.83	221.9	183.26	146.1	132.19
Total Liabilities	8,094	8,405	10,708	10,735	4,688
Common Stock	160.56	155.68	155.2	154.76	154.56
Additional Paid-In Capital	6,346	1,641	1,134	697.02	507.68
Retained Earnings	34,793	30,857	26,676	22,757	19,933
Comprehensive Income & Other	293.42	1,679	1,268	1,195	745.66
Total Common Equity	41,592	34,333	29,233	24,804	21,341
Minority Interest	-	-	-	-	44.9
Shareholders' Equity	41,592	34,333	29,233	24,804	21,386
Total Liabilities & Equity	49,686	42,738	39,941	35,539	26,074
Total Debt	35.89	278.9	3,777	5,724	545.59
Net Cash (Debt)	12,178	4,222	819.79	-3,032	20.92
Net Cash Growth	188.43%	415.01%	-	-	-99.68%
Net Cash Per Share	76.29	26.61	5.17	-19.36	0.14
Filing Date Shares Outstanding	160.56	155.68	155.19	154.76	154.56
Total Common Shares Outstanding	160.56	155.68	155.19	154.76	154.56
Working Capital	23,182	12,904	9,851	9,736	8,694
Book Value Per Share	259.05	220.54	188.37	160.28	138.07
Tangible Book Value	28,727	20,587	14,774	11,006	14,053
Tangible Book Value Per Share	178.92	132.24	95.20	71.12	90.92
Land	329.41	329.41	329.41	5.72	5.72
Buildings	3,315	3,234	3,111	2,925	2,833
Machinery	10,347	9,697	8,767	8,363	8,095
Construction In Progress	611.64	467	633.22	444.09	139.06